Jorge Gomez Tejeda Zanudo (Jorge Gómez Tejeda Zañudo, Jorge Gómez Tejeda Zañudo, Jorge Gómez Tejeda Zañudo)

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 11

Top Topics

Bioinformatics Analysis

Epidermal Growth Factor Receptor

Metastatic Breast Cancer

Top Venues

Nature communications

JCO precision oncology

Cancer research

Science advances

This page only lists publications with an associated author ORCID identifier.

Publications

Jorge Gomez Tejeda Zanudo, Romualdo Barroso-Sousa, Esha Jain, Qingchun Jin, Tianyu Li, Jorge E Buendia-Buendia, Alyssa M Pereslete, Daniel L Abravanel, Arlindo R Ferreira, Eileen Wrabel, Karla Helvie, Melissa E Hughes, Ann H Partridge, Beth A Overmoyer, Nancy U Lin, Nabihah Tayob, Sara M Tolaney, Nikhil Wagle
Exemestane plus everolimus and palbociclib in metastatic breast cancer: clinical response and genomic/transcriptomic determinants of resistance in a phase I/II trial. Nature communications 15 (1) (2024)
Jorge Gomez Tejeda Zanudo, Romualdo Barroso-Sousa, Esha Jain, Qingchun Jin, Tianyu Li, Jorge E Buendia-Buendia, Alyssa M Pereslete, Daniel L Abravanel, Arlindo R Ferreira, Eileen Wrabel, Karla Helvie, Melissa E Hughes, Ann H Partridge, Beth A Overmoyer, Nancy U Lin, Nabihah Tayob, Sara M Tolaney, Nikhil Wagle
Exemestane plus everolimus and palbociclib in metastatic breast cancer: clinical response and genomic/transcriptomic determinants of resistance in a phase I/II trial. Nature communications 15 (1) (2024)
Jorge Gomez Tejeda Zanudo, Romualdo Barroso-Sousa, Esha Jain, Qingchun Jin, Tianyu Li, Jorge E Buendia-Buendia, Alyssa M Pereslete, Daniel L Abravanel, Arlindo R Ferreira, Eileen Wrabel, Karla Helvie, Melissa E Hughes, Ann H Partridge, Beth A Overmoyer, Nancy U Lin, Nabihah Tayob, Sara M Tolaney, Nikhil Wagle
Exemestane plus everolimus and palbociclib in metastatic breast cancer: clinical response and genomic/transcriptomic determinants of resistance in a phase I/II trial. Nature communications 15 (1) (2024)
Jorge Gomez Tejeda Zanudo, Romualdo Barroso-Sousa, Esha Jain, Qingchun Jin, Tianyu Li, Jorge E Buendia-Buendia, Alyssa M Pereslete, Daniel L Abravanel, Arlindo R Ferreira, Eileen Wrabel, Karla Helvie, Melissa E Hughes, Ann H Partridge, Beth A Overmoyer, Nancy U Lin, Nabihah Tayob, Sara M Tolaney, Nikhil Wagle
Exemestane plus everolimus and palbociclib in metastatic breast cancer: clinical response and genomic/transcriptomic determinants of resistance in a phase I/II trial. Nature communications 15 (1) (2024)
Marla Lipsyc-Sharf, Esha Jain, Laura C Collins, Shoshana M Rosenberg, Kathryn J Ruddy, Rulla M Tamimi, Lidia Schapira, Steven E Come, Jeffrey M Peppercorn, Virginia F Borges, Ellen Warner, Craig Snow, Ian E Krop, Dewey Kim, Jakob H Weiss, Jorge Gomez Tejeda Zanudo, Ann H Partridge, Nikhil Wagle, Adrienne G Waks
Genomics of ERBB2 -Positive Breast Cancer in Young Women Before and After Exposure to Chemotherapy Plus Trastuzumab. JCO precision oncology 7 (2023)
Marla Lipsyc-Sharf, Esha Jain, Laura C Collins, Shoshana M Rosenberg, Kathryn J Ruddy, Rulla M Tamimi, Lidia Schapira, Steven E Come, Jeffrey M Peppercorn, Virginia F Borges, Ellen Warner, Craig Snow, Ian E Krop, Dewey Kim, Jakob H Weiss, Jorge Gomez Tejeda Zanudo, Ann H Partridge, Nikhil Wagle, Adrienne G Waks
Genomics of ERBB2 -Positive Breast Cancer in Young Women Before and After Exposure to Chemotherapy Plus Trastuzumab. JCO precision oncology 7 (2023)
Marla Lipsyc-Sharf, Esha Jain, Laura C Collins, Shoshana M Rosenberg, Kathryn J Ruddy, Rulla M Tamimi, Lidia Schapira, Steven E Come, Jeffrey M Peppercorn, Virginia F Borges, Ellen Warner, Craig Snow, Ian E Krop, Dewey Kim, Jakob H Weiss, Jorge Gomez Tejeda Zanudo, Ann H Partridge, Nikhil Wagle, Adrienne G Waks
Genomics of ERBB2 -Positive Breast Cancer in Young Women Before and After Exposure to Chemotherapy Plus Trastuzumab. JCO precision oncology 7 (2023)
Eli Newby, Jorge Gomez Tejeda Zanudo, Reka Albert
Structure-based approach to identifying small sets of driver nodes in biological networks. Chaos (Woodbury, N.Y.) 32 (6) (2022)
David J Wooten, Jorge Gomez Tejeda Zanudo, David Murrugarra, Austin M Perry, Anna Dongari-Bagtzoglou, Reinhard C Laubenbacher, Clarissa J Nobile, Reka Albert
Mathematical modeling of the Candida albicans yeast to hyphal transition reveals novel control strategies. PLoS computational biology 17 (3) (2021)
Jordan C Rozum, Jorge Gomez Tejeda Zanudo, Xiao Gan, Dávid Deritei, Reka Albert
Parity and time reversal elucidate both decision-making in empirical models and attractor scaling in critical Boolean networks. Science advances 7 (29) (2021)
Jorge Gomez Tejeda Zanudo, Pingping Mao, Clara Alcon, Kailey Kowalski, Gabriela N Johnson, Guotai Xu, Jose Baselga, Maurizio Scaltriti, Anthony G Letai, Joan Montero, Reka Albert, Nikhil Wagle
Cell Line-Specific Network Models of ER+ Breast Cancer Identify Potential PI3Kα Inhibitor Resistance Mechanisms and Drug Combinations. Cancer research 81 (17) (2021)